Biocryst Pharmaceuticals Inc (BCRX) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Biocryst Pharmaceuticals Inc (BCRX)

An SI Board Since January 2004

Posts	SubjectMarks	Bans	Symbol
269	15	0	BCRX

Emcee: SemiBull	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
194	Steve, keep a close tab for me! eom	zeta1961	-	9/21/2007
193	I don't recall having access to 1.25inch needles, again, fwiw, my experience	zeta1961	-	9/21/2007
192	Differing shot-giving techniques?..Yes..it seems that in the last decade or so n	zeta1961	-	9/21/2007
191	In your experience, do you see much problems with nurses giving shots, like wron	kenhott	-	9/21/2007
190	2 in needle... time to turn around and drop them. Better that way so you don	kenhott	-	9/21/2007
189	Should buy when Claude Bennett buys - and sell when he sells. secform4.com ste	Steve Lokness	-	9/21/2007
188	FWIW..I'd have used nothing less than 1.5 inches for an adult if IM is the o	zeta1961	-	9/21/2007
187	Interesting point. Use a 2 inch needle on me and it would come out the other sid	tom pope	-	9/20/2007
186	If it's data mining they've found one hell of a vein. It's not like	tom pope	-	9/20/2007
185	As has been pointed out, BCRX looked and discovered the needle length + CK line	kenhott	-	9/20/2007
184	George, I also believe that short term downside is limited. I sold some naked	Ian@SI	-	9/20/2007
183	EDIT: I see you and Rick have already discussed more than I could guess at. I	Ian@SI	-	9/20/2007
182	>> There no magic in the whole im/ck stuff << Well, I shouldn't	scaram(o)uche	-	9/20/2007
181	>> don't think blinding should have included blinding of CK <<	scaram(o)uche	-	9/20/2007
180	Your take is that the CK explanation was the result of a post hoc analysis? I d	Archie Meeties	-	9/20/2007
179	lightning fast study, blinded data must have looked all over map. this is obvio	scaram(o)uche	-	9/20/2007
178	i added to my position here. the study is externally funded, and i think furthe	mopgcw	-	9/20/2007
177	Ok if they were measuring CK's why didn't they catch on to the fact that	Archie Meeties	-	9/20/2007
176	Just listened to the BCRX cc replay. If one just listens to Stonehouse, you'	Ian@SI	-	9/20/2007
175	$5.85 was the low AH print (so far) Last trade at 8.08. Does this more than 35	Ian@SI	-	9/19/2007
174	they'll go with the single dose, phase III.	scaram(o)uche	-	9/19/2007
173	wow when it opened, I was just a second slow at getting it at 6. SIX! Ugh.	scaram(o)uche	-	9/19/2007
172	No, not out completely. This is the "seasonal" market, not the "	scaram(o)uche	-	9/19/2007
171	And taking the post hoc and going into ph3 regardless. Will be interesting to se	rkrw	-	9/19/2007
170	Peramivir whiffs in P2 >>BioCryst Reports Preliminary Results From a Phas	tuck	-	9/19/2007

Go to reply# or date (mm/dd/yy):